DGAP-News: Alphaform AG: Alphaform announces extensive realignment

| Source: EQS Group AG
DGAP-News: Alphaform AG / Key word(s): Profit Warning
Alphaform AG: Alphaform announces extensive realignment

03.02.2014 / 10:43


Corporate News Announcement

Alphaform AG 
Alphaform announces extensive realignment 

  - Restructuring, process improvement and competence extension as
    pre-requirement for further growth

  - Operational results forecast for 2013 is concretized at EUR-2.5 million

  - CEO gets support from interim manager

Feldkirchen, 03rd February 2014 - The industrial 3D printing service
provider Alphaform AG plans an extensive realignment. This is necessary due
to the rapid technological development that threatened to overtake the
company during the past business year.  In the future, the company will
focus on the 3D printing main business and on the creation of additional
customer benefits. The realignment is accompanied by a restructuring in the
organisation. It comprises the optimization of the operational processes
for recovering the profitability, the expansion of the sales activities to
increase revenues, as well as the enhancement of the own engineering
competences in order to use the growth chances in 3D printing.

The operational business will focus on a faster order addressing and a
better machine utilization with lower unit costs. Sales activity through
Key Account Management is further enhanced and additionally sales channels
e.g. online shopping and regional sales will be implemented. The first
steps were already introduced during the 4th quarter in 2013. In the
future, we will offer a more intensive engineering support - principally in
3D print-design - to the increasing number of customers, who are interested
in using 3D printing in their production.

Realignment and restructuring became necessary, when it became apparent
that Alphaform also forfeited to the earnings in the fourth quarter,
although the main business with prototypes and small series recovered to a
satisfactory level again. The analysis for this reason was -among others -
the reluctance to invest in the past, which led to increasing costs in
material and labour force and to a restricted use of the machinery.

According to the further decline in revenues in the fourth quarter of 2013
and the additional costs for the introduction of the realignment, Alphaform
concretises its present revenues forecast for the business year 2013 from
EUR-1.2 million to now EUR-2.5 million. Additionally, goodwill
amortizations at the implants subsidiary MediMet and individual impairment
(Einzelwertberichtigungen) are expected, which amount is not yet finally
determined. The revenues forecast of approx. EUR26 million is achieved.

Corporate Office extended 

In order to push along the realignment, the Executive Board promoted the
interim manager Dr. Hanns-Dieter Aberle. Aberle worked in the past eight
years as consultant and interim manager for mid-sized enterprises in
machine and plant construction, primarily in the areas industrial laser
technique and 3D printing, as well as in the segments portfolio management,
sales and innovation management.

During the restructuring phase, the finance area is reinforced advisory by
an experienced interim manager, Götz Ganghofer. Ganghofer has many years of
experience in restructuration and finance management.

About Alphaform

Alphaform AG, based in Feldkirchen near Munich was founded in 1996. The
company belongs to the European market leaders in the production of complex
components means additive manufacturing, which are often grouped together
under the term '3D printing'. An important mainstay of the segment 3D
Printing and Additive Manufacturing is the production of series close
prototypes, particularly for the automotive and capital goods industries.
The Medical Division of Alphaform has a leading position throughout Europe
in manufacturing and processing orthopaedic implants and instruments. The
shares of Alphaform are listed in the Prime Standard Segment of the
Frankfurt Stock Exchange (FWB) under the abbreviation ATF.

The core competence of Alphaform lies in its extensive application know-how
for processes and materials for the additive production of complex
prototypes, tools, individual components and small series made of plastic
and metal. The company's activity is focused on the orthopaedic and medical
technology, automotive, aviation and aerospace industries. The subsidiaries
of Alphaform are located in Germany, Finland, Sweden and the UK.

Dr. Thomas Vetter
Kapellenstraße 10
85622 Feldkirchen

Tel.: +49 89 905002 21
Fax: +49 89 9050021021
email: tvetter@alphaform.de 
Internet: www.alphaform.de

End of Corporate News


03.02.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language:    English                                               
Company:     Alphaform AG                                          
             Kapellenstraße 10                                     
             85622 Feldkirchen                                     
Phone:       +49 (0)89 905002 - 0                                  
Fax:         +49 (0)89 905002 - 90                                 
E-mail:      ir@alphaform.de                                       
Internet:    www.alphaform.de                                      
ISIN:        DE0005487953                                          
WKN:         548795                                                
Listed:      Regulierter Markt in Frankfurt (Prime Standard);      
             Freiverkehr in Berlin, Düsseldorf, Hamburg, München,  
End of News    DGAP News-Service  
250717 03.02.2014